SCHEMBL19783004

SCHEMBL19783004

CC(C)OC(=O)c1sc(N(COP(=O)(OC(C)(C)C)OC(C)(C)C)c2ncccn2)nc1-c1ccccn1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.34
GABRA5 P31644 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
KDM4E B2RXH2 6/20 0.32
ALDH1A1 P00352 5/20 0.32
HPGD P15428 4/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
F2 P00734 3/20 0.32
RAB9A P51151 2/20 0.32
KMT2A Q03164 2/20 0.32
F12 P00748 2/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
CYP1A2 P05177 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
ATM Q13315 1/20 0.32
TLR9 Q9NR96 1/20 0.32
HDAC3 O15379 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19782724 0.91 CDC7 (0.33) KDM4EALDH1A1HPGDRAB9AKMT2A
SCHEMBL19783110 0.85 LMNA (0.35) LMNAGABRA5KDM4EALDH1A1HPGD
SCHEMBL19782899 0.80 LMNA (0.42) LMNAGABRA5ADORA3KDM4EALDH1A1
SCHEMBL19782980 0.74 GRIA1 (0.44) LMNAADORA3KDM4EALDH1A1HPGD
SCHEMBL19782716 0.73 CDC7 (0.39) LMNAKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL19782897 0.72 CDC7 (0.38) KDM4EALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL19782898 0.72 ALDH1A1 (0.39) LMNAKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL15993672 0.70 LMNA (0.38) LMNAKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL19783003 0.69 ADORA3 (0.41) LMNAGABRA5ADORA3KDM4EALDH1A1
SCHEMBL29078801 0.60 KDM4E (0.53) LMNAKDM4EALDH1A1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10913734-B2 Substituted aminothiazoles BARUCH S. BLUMBERG INSTITUTE 2021-02-09 US disclosed
US-20190241552-A1 SUBSTITUTED AMINOTHIAZOLES BARUCH S. BLUMBERG INSTITUTE 2019-08-08 US disclosed
WO-2018013508-A1 SUBSTITUTED AMINOTHIAZOLES BARUCH S. BLUMBERG INSTITUTE (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10913734-B2 Substituted aminothiazoles ABAT, AADAT, BCAT1 LMNA 3743/4885GABRA5 1697/4885ADORA3 3568/4885
US-20190241552-A1 SUBSTITUTED AMINOTHIAZOLES ABAT, AADAT, BCAT1 LMNA 3743/4885GABRA5 1697/4885ADORA3 3568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.